How long should I take gefitinib?

The duration and duration of Gefitinib (Gefitinib) use will vary based on the patient's specific condition, disease progression, response to treatment, and physician recommendations. In general, gefitinib is used as part of long-term treatment to control the growth and spread of non-small cell lung cancer (NSCLC). For patients with EGFR mutation-positive NSCLC, gefitinib is usually continued when the disease is stable or in partial response to maintain disease control and improve survival. This may take months or even years, depending on individual circumstances. During treatment, doctors typically monitor patients closely for disease progression and drug tolerance. If the condition worsens or adverse reactions occur, the doctor may adjust the treatment plan, possibly by changing medications or using other treatments.